Uncategorized

Shell Midstream Partners Shares Quiet Amid Headline US Has Started Work Needed To Enable Temporary Waiver Of Jones Act After Colonial Pipeline Attack

-Reuters

byBenzinga Newsdesk

May 11, 2021

1 minute read

-Reuters

Roth Capital Initiates Coverage On Verano Holdings with Buy Rating, Announces Price Target of $35

By Benzinga Newsdesk

Today, 1:40 PM

Roth Capital analyst Scott Fortune initiates coverage on Verano Holdings (OTC:VRNOF) with a Buy rating and announces Price Target of $35.

VRNOF

News

Return On Capital Employed Overview: Jacobs Engineering Group

By Benzinga Insights

Today, 1:40 PM

Jacobs Engineering Group (NYSE:J) reported Q2 sales of $3.55 billion. Earnings fell to a loss of $41.11 million, resulting in a 119.22% decrease from last quarter. Jacobs Engineering Group reached earnings of $213.94 million and sales of $3.38 billion in Q1.

EyePoint Pharmaceuticals Announces First Patient Dosed In Phase 2 PAVIA Clinical Trial Of EYP-1901 For The Treatment Of Non-Proliferative Diabetic Retinopathy

By Benzinga Newsdesk

Today, 1:40 PM

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced that the first

EYPT

$56M In Ethereum Was Just Transferred Between 2 Wallets

By Benzinga Insights

Today, 1:40 PM

What happened: $56,438,975 worth of Ethereum (CRYPTO: ETH) was just moved between 2 anonymous cryptocurrency wallets in a single transaction. This mysterious person's Ethereum wallet address has been identified as: 0xe3786bf25e15013fdda09dbe881529d44b9ca239

ETH

Shell Midstream Partners Shares Quiet Amid Headline US Has Started Work Needed To Enable Temporary Waiver Of Jones Act After Colonial Pipeline Attack

Related Posts

Roth Capital Initiates Coverage On Verano Holdings with Buy Rating, Announces Price Target of $35

Return On Capital Employed Overview: Jacobs Engineering Group

EyePoint Pharmaceuticals Announces First Patient Dosed In Phase 2 PAVIA Clinical Trial Of EYP-1901 For The Treatment Of Non-Proliferative Diabetic Retinopathy

$56M In Ethereum Was Just Transferred Between 2 Wallets